Journal:

Article Title: Novel Antibacterial Class

doi: 10.1128/AAC.47.12.3831-3839.2003

Figure Lengend Snippet: Antibacterial activity of A-692345 against clinically resistant S. pneumoniae and S. aureus

Article Snippet: Antibacterial spectrum of NRI compounds table ft1 table-wrap mode="anchored" t5 TABLE 3. caption a7 Organism Resistance a MIC (μg/ml) A-692345 Levofloxacin S. pneumoniae ATCC 6303 32 0.5 ATCC 49619 PEN 16 1 ATCC 5957 PEN 16 1 ATCC 7257 LVX 4 8 ATCC 6396 ERY b , CLX, TET 16 1 ATCC 5649 PEN, ERY c 8 4 S. aureus ATCC 29213 32 0.25 ATCC 1350 PEN, ERY, CLX 32 0.12 ATCC 7667 PEN, OXA 32 0.25 ATCC 7702 PEN, OXA, CHL, TET, GEN, CIP 32 16 ATCC 2175 PEN, OXA, ERY, CLX, TET, GEN, CHL 32 0.25 ATCC 7681 PEN, OXA, ERY, CLX, CHL, GEN, CIP 32 8 ATCC 3405 PEN, OXA, ERY, CLX, TET, GEN, CIP 32 16 Open in a separate window a Resistance phenotype determined by NCCLS criteria (data not shown).

Techniques: Activity Assay